Inuprin Forte

Inosine Pranobex, the active ingredient in Inuprin Forte, is an immunomodulator presented as an oral formulation for oral use. It modulates the immune response and exhibits antiviral activity, and is employed in the management of certain viral infections in adults.

GNH USA supplies Inuprin Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory‑compliant distribution across multiple markets, ensuring a reliable supply chain for timely delivery to healthcare providers.

Inosine Pranobex is used primarily for viral infections and related immune‑mediated conditions.

- Herpes simplex infections: reduces lesion duration and severity. - Influenza virus infections: shortens the course of illness and alleviates symptoms. - Human papillomavirus (HPV) warts: promotes regression of cutaneous warts by enhancing immune clearance.

Inosine Pranobex may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Mild fever: low‑grade temperature rise. - Abdominal discomfort: occasional cramps or pain.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rash, swelling, breathing difficulty. - Liver enzyme elevation: signs of hepatic stress. - Hematologic abnormalities: thrombocytopenia or anemia.

Before prescribing Inosine Pranobex, clinicians should consider several safety aspects. - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: caution advised; monitor infant for adverse effects. - Hepatic impairment: monitor liver function tests regularly. - Renal impairment: adjust use based on renal function. - Concomitant immunosuppressants: increased risk of reduced efficacy. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Inosine Pranobex can interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Immunosuppressants (e.g., cyclosporine): may diminish antiviral efficacy. - Live attenuated vaccines: increased risk of vaccine‑derived infection.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): potential alteration of coagulation parameters. - Corticosteroids: additive immunomodulation may affect therapeutic response. - Alcohol: may increase hepatic stress and exacerbate liver‑related side effects.